Segal Lloyd Mitchell

Avg. Two Year Performance

166% Avg. Purchase Return
63% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%20%30%54%166%
Purchase Success Rate2 of 22 of 22 of 22 of 22 of 2
Average Sale Return< 1%0%0%0%0%
Sale Success Rate1 of 30 of 30 of 30 of 30 of 3

Repare Therapeutics Inc.

Other » Other

President and CEO, Director:

Holdings: 210.24K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Valeant Pharmaceuticals Int...

Drugs » Drug Delivery

Director:

Holdings: 21.17K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--